kratom and semaglutide Kratom: the risky new substance you need to know about medication | University of Utah

GLP-1GLP-1SGLT2

This study aimed to compare durability of treatment efficacy of once-weekly (OW) semaglutide for T2D with that of the dipeptidyl peptidase 4 inhibitor (DPP4i) class

N-terminal 48.35.9%), liver (N-terminal 41.43.8%), and peripheral tissues (C-terminal 42.36.0%

For the eleventh year running, Endocrine News talks to editors from Endocrine Society publications to unearth the most impressive breakthroughs in endocrine science and research for 2025

A Korean study has found that probiotic strain Limosilactobacillus fermentum GB102 could enhance GLP-1 receptor agonist (RA) dulaglutide in obesity treatment. The study details that although GLP-1 RA treatments are effective for weight loss, when discontinued, weight regain is common